State Street Corp Pa Vmed Inc. Transaction History

State Street Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.56 $11,970 - $19,152	-34,200 Reduced 10.84%	281,389 $115,000
Q3 2022 Nov 15, 2022	SELL	$0.57 - $34.65 $5,471 - $332,640	-9,600 Reduced 2.95%	315,589 $271,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $995,644 - $1.65 Million	-1,171,347 Reduced 78.27%	325,189 $304,000
Q1 2022 May 16, 2022	BUY	$1.16 - $2.5 $140,001 - $301,727	120,691 Added 8.77%	1,496,536 $1.98 Million
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $3.15 Million - $11.2 Million	-1,278,513 Reduced 48.17%	1,375,845 $3.39 Million
Q3 2021 Nov 15, 2021	BUY	$5.1 - $9.39 $7.44 Million - $13.7 Million	1,458,939 Added 122.04%	2,654,358 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $1.44 Million - $2.5 Million	363,716 Added 43.73%	1,195,419 $7.65 Million
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $641,055 - $1.77 Million	318,933 Added 62.2%	831,703 $3.69 Million
Q4 2020 Feb 16, 2021	BUY	$1.73 - $2.13 $166,081 - $204,482	96,001 Added 23.03%	512,770 $1.09 Million
Q3 2020 Nov 10, 2020	BUY	$1.76 - $2.17 $104,888 - $129,323	59,596 Added 16.69%	416,769 $742,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.65 $625,052 - $946,508	357,173 New	357,173 $754,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $60.1M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.